July 22 (Reuters) - Laboratory operator Quest Diagnostics (DGX.N), opens new tab raised its 2025 profit and revenue forecasts on Tuesday, banking on robust demand for its diagnostic tests, sending the ...

Octave is collaborating with Quest Diagnostics to expand access to its MSDA blood test, used to measure disease activity in ...

The test may potentially improve patient care for kidney transplant patients while helping to lower sizeable healthcare costs associated with renal transplant failure. The new test is based on the RNA ...

Quest Diagnostics has introduced a new pharmacogenomic (PGx) laboratory testing service designed to assist healthcare providers in understanding their patients' genetic responses to specific ...

July 26 (Reuters) - Laboratory operator Quest Diagnostics Inc (DGX.N), opens new tab beat estimates for quarterly profit on Wednesday, as people returned for regular checkups and tests that were ...

Octave Bioscience, a commercial-stage precision care company pioneering a new standard for managing multiple sclerosis (MS) ...

Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...

GRAIL's Galleri Test Now Directly Available to Physicians in the U.S. Through Collaboration With Quest Diagnostics, Delivering a More Streamlined Provider and Patient Experience MENLO PARK, Calif. and ...

Hims & Hers obtains YourBio's microsampling tech, which the firm said will speed its efforts to improve blood collection, including outside traditional clinical settings.

Quest Diagnostics announced the availability of a new laboratory test that identifies molecular changes to cervical cells that increase the likelihood a woman may develop cervical cancer. The test is ...

With demand for COVID-19 tests rapidly drying up, testmakers like Quest Diagnostics are scrambling to find deeper waters that’ll keep them from running aground. Quest, for one, is banking on its core ...

Lab testing companies including giants Quest Diagnostics and LabCorp are pressing Congress to stop hundreds of millions of dollars of Medicare cuts for diagnostic tests that are due to take effect at ...